Institutional investors purchased a net $7.6 million shares of MBIO during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 16.87% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LAURION CAPITAL MANAGEMENT LP Bought 1.4 Million shares of Mustang Bio Inc
MILLENNIUM MANAGEMENT LLC Bought 627.0 Thousand shares of Mustang Bio Inc
CITADEL ADVISORS LLC Bought 403.1 Thousand shares of Mustang Bio Inc